Sunflower Bank N.A. Has $378,000 Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Sunflower Bank N.A. lifted its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.6% during the 4th quarter, HoldingsChannel reports. The fund owned 725 shares of the medical equipment provider’s stock after acquiring an additional 25 shares during the quarter. Sunflower Bank N.A.’s holdings in Intuitive Surgical were worth $378,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Godsey & Gibb Inc. increased its holdings in shares of Intuitive Surgical by 140.0% during the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 35 shares during the period. MidAtlantic Capital Management Inc. acquired a new stake in Intuitive Surgical during the third quarter worth approximately $33,000. Capital Performance Advisors LLP bought a new position in Intuitive Surgical during the 3rd quarter worth $38,000. DT Investment Partners LLC raised its holdings in Intuitive Surgical by 80.0% in the 3rd quarter. DT Investment Partners LLC now owns 81 shares of the medical equipment provider’s stock valued at $40,000 after acquiring an additional 36 shares in the last quarter. Finally, Mark Sheptoff Financial Planning LLC bought a new stake in shares of Intuitive Surgical during the 2nd quarter valued at $37,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, SVP Mark Brosius sold 2,128 shares of the business’s stock in a transaction on Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total transaction of $1,095,920.00. Following the completion of the sale, the senior vice president now owns 273 shares in the company, valued at approximately $140,595. The trade was a 88.63 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, EVP Brian Edward Miller sold 2,553 shares of the firm’s stock in a transaction on Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total transaction of $1,314,795.00. Following the completion of the transaction, the executive vice president now directly owns 7,066 shares in the company, valued at $3,638,990. This trade represents a 26.54 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 48,190 shares of company stock valued at $25,012,927. 0.90% of the stock is currently owned by company insiders.

Intuitive Surgical Price Performance

Shares of Intuitive Surgical stock traded down $7.72 during trading on Monday, hitting $539.75. The company’s stock had a trading volume of 1,433,191 shares, compared to its average volume of 1,351,010. The stock has a market cap of $192.25 billion, a price-to-earnings ratio of 86.78, a price-to-earnings-growth ratio of 5.31 and a beta of 1.39. Intuitive Surgical, Inc. has a 52 week low of $355.17 and a 52 week high of $556.23. The stock has a 50-day moving average price of $535.93 and a two-hundred day moving average price of $495.17.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, beating analysts’ consensus estimates of $1.24 by $0.32. The firm had revenue of $2.04 billion for the quarter, compared to analyst estimates of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. On average, equities analysts predict that Intuitive Surgical, Inc. will post 5.45 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of research analysts recently commented on ISRG shares. Truist Financial raised their price target on Intuitive Surgical from $570.00 to $640.00 and gave the stock a “buy” rating in a research report on Wednesday, December 18th. JPMorgan Chase & Co. boosted their target price on shares of Intuitive Surgical from $495.00 to $575.00 and gave the company an “overweight” rating in a research report on Friday, October 11th. Evercore ISI reiterated a “cautious” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Robert W. Baird lifted their price objective on shares of Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a research note on Thursday, October 17th. Finally, Royal Bank of Canada upped their target price on Intuitive Surgical from $525.00 to $555.00 and gave the stock an “outperform” rating in a research note on Friday, October 18th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have assigned a buy rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $554.17.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.